| NCT ID | NCT06581692 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Miscarriage in First Trimester |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2039-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-09-01 with a primary completion date of 2039-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test. This study aims to determine the level of cell-free DNA (cfDNA) in early pregnancy and compare the results with those of product of conception (POC) testing, in concordance with standard karyotyping.
Eligibility Criteria
Inclusion Criteria: 1. Age 18-45 years. 2. Women who attend the early pregnancy loss clinic or Patients who receive ART 3. Their partner, the biological father of the pregnancy Exclusion Criteria: * History of psychological/ psychiatric problem * Patient refusal
Contact & Investigator
PUI WAH JACQUELINE CHUNG
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT06581692 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Miscarriage in First Trimester. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06581692 currently recruiting?
Yes, NCT06581692 is actively recruiting participants. Contact the research team at jacquelinechung@cuhk.edu.hk for enrollment information.
Where is the NCT06581692 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06581692 clinical trial?
NCT06581692 is sponsored by Chinese University of Hong Kong. The principal investigator is PUI WAH JACQUELINE CHUNG at Chinese University of Hong Kong. The trial plans to enroll 150 participants.